| Literature DB >> 34778779 |
Adam I Green1, George M Burslem1,2.
Abstract
Discovery of epigenetic chemical probes is an important area of research with potential to deliver drugs for a multitude of diseases. However, commercially available libraries frequently used in drug discovery campaigns contain molecules that are focused on a narrow range of chemical space primarily driven by ease of synthesis and previously targeted enzyme classes (e.g., kinases) resulting in low hit rates for epigenetic targets. Here we describe the design and synthesis of a compound collection that augments current screening collections by the inclusion of privileged isosteres for epigenetic targets. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 34778779 PMCID: PMC8528209 DOI: 10.1039/d1md00193k
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682